Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccineDAUNER, Joseph G; YUANJI PAN; HILDESHEIM, Allan et al.Vaccine. 2010, Vol 28, Num 33, pp 5407-5413, issn 0264-410X, 7 p.Article

Antibody response to human papillomavirus vaccine in subjects with inherited bone marrow failure syndromesALTER, Blanche P; GIRI, Neelam; YUANJI PAN et al.Vaccine. 2014, Vol 32, Num 10, pp 1169-1173, issn 0264-410X, 5 p.Article

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protectionKEMP, Troy J; HILDESHEIM, Allan; SAFAEIAN, Mahboobeh et al.Vaccine. 2011, Vol 29, Num 11, pp 2011-2014, issn 0264-410X, 4 p.Article

Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine TrialSAFAEIAN, Mahboobeh; PORRAS, Carolina; HERRERO, Rolando et al.Cancer prevention research (Philadelphia, Pa.). 2013, Vol 6, Num 11, pp 1242-1250, issn 1940-6207, 9 p.Article

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix^®KEMP, TroyJ; SAFAEIAN, Mahboobeh; HILDESHEIM, Allan et al.Vaccine. 2012, Vol 31, Num 1, pp 165-170, issn 0264-410X, 6 p.Article

Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in UgandaLAMONTAGNE, D. Scott; MUGISHA, Emmanuel; YUANJI PAN et al.Vaccine. 2014, Vol 32, Num 47, pp 6303-6311, issn 0264-410X, 9 p.Article